Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 14Colonic Neoplasms 11Rectal Neoplasms 10Stomach Neoplasms 8Cholangiocarcinoma 8Neoplasm Metastasis 7Esophageal Neoplasms 3Carcinoma, Hepatocellular 3Neoplasms 2Liver Neoplasms 2Cirrhosis, Familial, with Pulmonary Hypertension 2Adenocarcinoma Of Esophagus 2Pancreatic Neoplasms 1Ovarian Neoplasms 1Genetic Diseases, Inborn 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Colorectal Adenocarcinoma Metastatic to the Liver 1Carcinoma, Pancreatic Ductal 1Carcinoma, Ovarian Epithelial 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1Adrenocortical Carcinoma 1Adrenal Gland Neoplasms 1Adrenal Cortex Neoplasms 1

Interventions

Melphalan 3thymoglobulin 1sargramostim 1romidepsin 1keyhole-limpet hemocyanin 1ixazomib 1Thalidomide 1Tablets 1Streptozocin 1Radiosurgery 1Radiation 1Mercaptopurine 1Leucovorin 1Ketoconazole 1Fulvestrant 1Floxuridine 1FANG vaccine 1Docetaxel 1Clinical Trials, Phase II as Topic 1Carmustine 1Antilymphocyte Serum 1Alpelisib 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Genetic Diseases, Inborn × Floxuridine × Clear all
NCT00019760 2023-10-31

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡